22157.jpg
Engineered Multispecific Antibodies Innovation Research Report 2024: Patent Trends Show a Noticeable Surge in 2023 with Regeneron, Roche, and Amgen Emerging as the Top Patent Filers
17 janv. 2025 04h57 HE | Research and Markets
Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The "Innovation Insights: Engineered Multispecific antibodies" report has been added to ResearchAndMarkets.com's offering.Engineered multispecific...
Global Systemic Lupus Erythematosus Market
Systemic Lupus Erythematosus (SLE) Market Forecast at $6.19 Billion by 2034: In-Depth Analysis by Drug Class, Route of Administration, Distribution Channel and Region
16 janv. 2025 04h02 HE | Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "Systemic Lupus Erythematosus Market by Drug Class, Route of Administration, Distribution Channel, and Region" report has been added to ...
22157.jpg
Biotherapeutics Market Insights 2025, Analysis and Forecast to 2030: Insulin Demand Soars Amid Diabetes Epidemic, Sees $40 Billion Opportunity
13 janv. 2025 06h40 HE | Research and Markets
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Biotherapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type" report...
22157.jpg
Bioprocess Optimization and Digital Bio-manufacturing Global Market Report 2025: Demand for Biologics Fuels Rapid Growth in Advanced Bioprocess Technologies and Analytics
13 janv. 2025 04h29 HE | Research and Markets
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Bioprocess Optimization and Digital Bio-manufacturing: Global Markets" report has been added to ResearchAndMarkets.com's offering. Over the last few...
Cancer Immunotherapy Market
Cancer Immunotherapy Global Market Overview 2023-2030, Competitive Analysis of Amgen, AstraZeneca,Bayer, BMS, Eli Lilly, F. Hoffmann-La Roche, GSK, Immunocore, J&J, Merck, Novartis, Pfizer
10 janv. 2025 04h06 HE | Research and Markets
Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global market for Cancer Immunotherapy...
Global Antibodies Contract Manufacturing Market
Antibodies Contract Manufacturing Market Research 2024 with Global Long-term Forecasts to 2035: Expansion of Emerging Markets, Personalized Medicine, Therapeutic Antibodies Demand Fueling Growth
08 janv. 2025 11h42 HE | Research and Markets
Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Antibodies Contract Manufacturing Market by Product, by Source, by End-User, and By Region" report has been added to ResearchAndMarkets.com's...
Global Cell Harvesting System Market
Cell Harvesting Systems Market to Cross Revenues of $26.6 Billion by 2034 - Evolving Healthcare Landscape Spurs Demand for Regenerative Medicine and Cell-Based Therapies
08 janv. 2025 10h28 HE | Research and Markets
Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Cell Harvesting System Market by Type, Application, End User and Region" report has been added to ResearchAndMarkets.com's offering. This...
22157.jpg
8MM Respiratory Syncytial Virus Prophylaxis Market Drug Analysis Report: Prophylactic Options to Continue to Diversify Due to Strength of Late-Stage Pipeline - Forecast to 2030
20 déc. 2024 10h05 HE | Research and Markets
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus Prophylaxis: Eight-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's...
22157.jpg
Myositis Therapeutics Market Report 2024: Comprehensive Insights about 18+ Companies and 20+ Pipeline Drugs
18 déc. 2024 09h37 HE | Research and Markets
Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Myositis - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
BioUsawa.png
Bio Usawa Names Former Ghana Food and Drug Authority Director Eric Karikari-Boateng as Head of Global Regulatory Strategy
17 déc. 2024 10h15 HE | Bio Usawa Inc
Bio Usawa, Inc., a company committed to delivering affordable biotherapies in Africa, named Eric Karikari-Boateng its Head of Global Regulatory Strategy